Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
18. September 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9076
Articles 1 - 20 / 181518
Prognostic value and immune landscape implications of using a novel homologous recombination repair pathway signature in prostate cancer: A retrospective cohort study.
J Int Med Res
Wang F, Tian YE, Liu Q, Sha MO, Wang P, Huang X, Tuoheti K, Chen J, Cui QI.
PMID: 42754412 [PubMed - indexed for MEDLINE]
From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX-Targeted [(68)Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [(18)F]FDG PET/CT.
J Nucl Med
Kömek H, Arslan E, Can C, Akgün E, K, Yüceta, Akdeniz N, Çermik TF, Urakç, Do, Bardakç, Yeprem Ö, Kural AR.
PMID: 42754347 [PubMed - as supplied by publisher]
Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.
Cancer Immunol Res
Rafael TS, Gil-Jimenez A, Elst L, de Vries HM, Seignette IM, Bekers E, Lopez-Yurda M, Peters D, Nieuwland M, Hooijberg E, Broeks A, Brouwer OR, Schaake EE, Lambrechts D, Wessels LFA, Vis DJ, Albersen M, de Gruijl TD, van der Heijden MS.
PMID: 42754263 [PubMed - as supplied by publisher]
Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives.
J Immunol Res
Shi R, Ran L, Song T, Zhou X, Zhao W, Zhang Y.
PMID: 42753002 [PubMed - indexed for MEDLINE]
Safety and patient-reported outcomes of multimodal PSMA PET/MRI-guided prostate biopsy: results from the prospective multicenter DEPROMP trial.
World J Urol
Schmidt CJ, Reichert T, Gaertner FC, Kreppel B, Essler M, Luetkens JA, Attenberger U, Anspach M, Ohlmann CH, Hauser S, Ellinger J, Ritter M, Krausewitz P.
PMID: 42752988 [PubMed - indexed for MEDLINE]
Multimodal large language models for bladder tumor detection in cystoscopy: a retrospective benchmarking study.
World J Urol
Prat Y, Mahmud H, Tsur A, Laufer M, Orkin D, Dotan ZA, Rosenzweig B.
PMID: 42752986 [PubMed - indexed for MEDLINE]
Night work and cancer risk: results from the ELSA-Brasil worker cohort.
Rev Saude Publica
Bernardino DCAM, Otero UB, Pimenta IT, Griep RH, Giatti L, Barreto SM, Fonseca MJMD.
PMID: 42752711 [PubMed - indexed for MEDLINE]
Perirenal fat stranding on preoperative imaging is associated with a prolonged operative time in pediatric radical nephrectomy.
Pediatr Surg Int
Ebihara M, Deie K, Matsuda R, Tsuzaka S, Taki S, Ogawa S, Kawashima H.
PMID: 42752704 [PubMed - indexed for MEDLINE]
Current Trends in Therapeutic Outcomes Among Patients With Metastatic Renal Cell Carcinoma of the Spine: A Systematic Review and Meta-Analysis.
Global Spine J
Ndika TC, Woo J, Lee BT, Johnson E, Oguguo E, Rivera N, Ray EJ, Bello A, Tiako JD, Mohamed L, Larry Lo SF, Sciubba DM, De la Garza Ramos R, O'Toole JE, Chongsathidkiet P, Dalton T, Crowell KA, Von Isenburg M, Mullikin T, Erickson M, Goodwin CR.
PMID: 42751937 [PubMed - as supplied by publisher]
Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies.
Cancer
Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA.
PMID: 42751801 [PubMed - indexed for MEDLINE]
Immunotherapy role in bladder cancer treatment: a review of literature.
Front Oncol
Thalambedu N, Vasipalli K, Sampath Kumar N, Vellanki S, Trikannad AK, Gullapalli M, Tu SM, Kunthur A.
PMID: 42751111 [PubMed]
Reviving cancer vaccines in renal cell carcinoma: a new chapter in immunotherapy for kidney cancer.
Immunooncol Technol
Scallo FM, Ishizuka JJ, Braun DA.
PMID: 42751052 [PubMed]
The use of artificial intelligence and wearable devices in enhanced recovery after surgery pathways following radical cystectomy: A systematic review.
J Int Med Res
Feyissa M, Baheer Y, Ahmed B, Rosa N, Dubey S, Thillaivasan K, Philippou Y, Odeh R, Muheilan M, Khetrapal P, Catto JW, Kelly JD, Chiruvella M, Vasdev N.
PMID: 42750161 [PubMed - indexed for MEDLINE]
Prognostic value of baseline PSMA PET/CT for survival in synchronous metastatic hormone-sensitive prostate cancer: towards redefining low- and high-volume disease.
Eur Radiol
Kleiburg F, Heijmen L, Witteveen A, van Duuren K, Zuidgeest P, Smit F, de Geus-Oei LF, van der Hulle T.
PMID: 42749930 [PubMed - as supplied by publisher]
Prostate Cancer Screening: The Population Benefit Outweighs the Harm (Pro).
Eur Urol Focus
Carlsson SV, van den Bergh R.
PMID: 42749606 [PubMed - as supplied by publisher]
Re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019.
Eur Urol
Longoni M, Gandaglia G, Montorsi F.
PMID: 42749562 [PubMed - as supplied by publisher]
Reply to Roberto Mario Scarpa's Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12.
Eur Urol Oncol
Contieri R, Hurle R.
PMID: 42749558 [PubMed - as supplied by publisher]
Recognizing the significance of cancer-nerve crosstalk in advanced prostate cancer.
Adv Cancer Res
Bhattacharya S, Nag N, Singh SK, Datta K, Dutta S.
PMID: 42749384 [PubMed - indexed for MEDLINE]
[Molecular Diagnostics and Personalized Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC)].
Aktuelle Urol
Semmler M, Casuscelli J, Zschäbitz S, Jann JC.
PMID: 42748971 [PubMed - as supplied by publisher]
Natural product-derived compounds modulating STAT3 signaling in prostate cancer: Mechanistic insights and therapeutic potential.
Biomed Pharmacother
Feng Y, Liu D, Gu C, Zhou T, Zhang Z, Bonnet PA, Meng X.
PMID: 42748829 [PubMed - as supplied by publisher]
Articles 1 - 20 / 181518
Page 1 of 9076
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy